ONX
- Product code
- ONX
- Device name
- Ovarian Adnexal Mass Assessment Score Test System
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.6050
- Medical specialty
- Obstetrics/Gynecology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 6 (all years; only the last 3 years are listed here)
FDA classification definition
An ovarian/adnexal mass assessment test is a devicem that measures one or more proteins in serum. It yields a single result for the likelihood that an adnexal pelvic mass in a woman, for whom surgery is planned, is malignant. The test isn for adjunctive use, in teh context of a negative primary clinical and radiological evaluation, to augmrent the identification of patienets whose gynecologic surgery requires oncology expertise and resources.
Official FDA classification page: ONX
Classification and pathway per current FDA publications. Data from openFDA (CC0).